Among our recent financing matters, we have represented:

• Aria CV, Inc., a company developing a medical device designed to improve the lives of patients living with pulmonary hypertension, in multiple rounds of venture capital financing.
• BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) in several underwritten, registered direct and PIPE offerings.
• Francis Medical, Inc., a medical device company developing a therapy to treat prostate cancer, in multiple rounds of venture and strategic financing.
• EarliTec Diagnostics, Inc., a company developing a device used to detect autism, in multiple rounds of venture financing.
• HistoSonics, Inc., a company developing a therapy platform used for the destruction of liver tumors, in multiple rounds of venture financing.
• iotaMotion, Inc., a company developing robotics-assisted technologies for use in cochlear implantation and related ENT procedures, in multiple rounds of venture capital financing.
• InterShunt Technologies, Inc., a company developing a transcatheter system to reduce symptoms in heart failure patients, in multiple rounds of venture capital financing.
• iVEAcare, Inc., a company developing neuromodulation technology to treat patients suffering from chronic diseases, in a venture capital financing.
• LifeLens Technologies, Inc., a company developing a physiologic monitoring system, in multiple rounds of venture financing.
• LaPlace Interventional, Inc., a company developing a transcatheter tricuspid valve replacement system, in multiple venture and strategic financings.
• Medical Transcription Billing, Corp. (NASDAQ: MTBC), a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, in its initial public offering.
• Monteris Medical Corporation, a neurosurgical device company, in multiple rounds of venture financing.
• Nuvaira, Inc., a company developing minimally invasive products to make breathing easier for patients suffering from obstructive lung diseases, in multiple rounds of venture financing.
• Oculogica, Inc., a company that has developed a concussion assessment system, in multiple rounds of venture financing.
• ReShape Lifesciences, Inc., a company focused on the design, development and commercialization of transformative technologies to treat obesity and metabolic diseases, in its initial public offering.
• Rotation Medical, Inc., a medical device company with products to treat rotator cuff disease, in multiple rounds of venture capital financing.
• Sonex Health, Inc., a company that has developed ultrasound guided solutions, in multiple rounds of venture capital financing.
• Spineology Inc., a medical technology company focused on next-generation spinal technology, in multiple rounds of venture financing.
• Torax Medical, Inc., a venture capital-backed medical device company with products to treat gastro-esophageal reflux disease, in multiple rounds of venture financing.
• Tornier N.V. (NASDAQ: TRNX), a premier high-growth extremities and biologics company, in its $210 million underwritten public offering.
• Visura Technologies, Inc., a company that has developed technology that aids in the quality of transesophageal echocardiogram probe intubations, in multiple rounds of venture financing.